Summary of Significant Accounting Policies - Narrative (Details)		3 Months Ended		12 Months Ended
	Aug. 17, 2021	Mar. 31, 2025 USD ($) product $ / shares shares	Mar. 31, 2024 USD ($)	Dec. 31, 2024 USD ($)	Sep. 26, 2022 $ / shares shares
Summary Of Significant Accounting Policies [Line Items]
Number of preclinical products in development | product		3
Allowance for doubtful accounts				$ 100,000
Allowance for credit losses		$ 0		0
Receivables written off		0		0
Loss contingency accrual		$ 0		$ 0
Employee Stock Option
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive securities excluded from computation of earnings per share (in shares) | shares		3,435,449
Employee Stock Purchase Plan
Summary Of Significant Accounting Policies [Line Items]
Offering period	6 months	6 months
Private Placement Financing | Purchase Agreement | Pre-Funded Warrant
Summary Of Significant Accounting Policies [Line Items]
Number of warrants issued to purchase common stock (in shares) | shares					2,426,493
Warrants exercise price (in dollars per share) | $ / shares		$ 0.0001			$ 0.0001
Private Placement Financing | Purchase Agreement | Pre-Funded Warrant - March 2025
Summary Of Significant Accounting Policies [Line Items]
Number of warrants issued to purchase common stock (in shares) | shares		20,076,500
Private Placement Financing | Purchase Agreement | Pre-Funded Warrant - September 2022
Summary Of Significant Accounting Policies [Line Items]
Number of warrants issued to purchase common stock (in shares) | shares		2,426,493
Product Sales Allowance
Summary Of Significant Accounting Policies [Line Items]
Deduction from gross product sales for allowances		$ 2,085,000	$ 1,084,000
Minimum
Summary Of Significant Accounting Policies [Line Items]
Property and equipment estimated useful lives		3 years
Maximum
Summary Of Significant Accounting Policies [Line Items]
Property and equipment estimated useful lives		5 years
Term of options granted		10 years
Customer One | Revenue Benchmark | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk percentage		37.00%	48.00%
Customer One | Accounts Receivable | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk percentage			51.00%
Customer Two | Revenue Benchmark | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk percentage		60.00%	52.00%
Customer Two | Accounts Receivable | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk percentage			49.00%